Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...

In a report released today, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...

The global neuromuscular disease therapeutics market is projected to grow by $13.73 billion between 2025 and 2029, according ...

Truist has initiated coverage of Larimar (LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory ...

While the strategic review process is underway, Sage Therapeutics continues to advance its mission of pioneering solutions to deliver life-changing brain health medicines. The company is committed to ...

US stocks closed in the red on Wednesday after the Federal Reserve said it would bide its time before making any further ...

Boston Properties (NYSE:BXP) reported its fourth-quarter 2024 earnings, revealing a significant miss on earnings per share ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

Spotify Technology S.A. 1.51% $104.03B ...

Samsung Electronics Co. Ltd. 0.00% ₩356.7T ...

Bonus Jun 30, 2022 Jul 01, 2022 May 17, 2022 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Mar 15, 2018 Mar 17, 2018 Jan 30, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 18, ...

NTPC Ltd., incorporated in the year 1975, is a Large Cap company (having a market cap of Rs 3,08,596.40 Crore) operating in Power sector. NTPC Ltd. key Products/Revenue Segments include Generation Of ...